Successfully implemented artificial intelligence and machine learning applications in cardiology: state-of-the-art review

J Van den Eynde, M Lachmann, KL Laugwitz… - Trends in cardiovascular …, 2023 - Elsevier
The omnipresence and deep impact of artificial intelligence (AI) in today's society are
undeniable. While the technology has already established itself as a powerful tool in several …

Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: a randomized clinical trial

R Scragg, AW Stewart, D Waayer, CMM Lawes… - JAMA …, 2017 - jamanetwork.com
Importance Cohort studies have reported increased incidence of cardiovascular disease
(CVD) among individuals with low vitamin D status. To date, randomized clinical trials of …

Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study

R Pylypchuk, S Wells, A Kerr, K Poppe, T Riddell… - The Lancet, 2018 - thelancet.com
Background Most cardiovascular disease risk prediction equations in use today were
derived from cohorts established last century and with participants at higher risk but less …

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials

A Salam, E Atkins, J Sundström, Y Hirakawa… - Journal of …, 2019 - journals.lww.com
Objective: To assess the clinical relevance of regression to the mean for clinical trials and
clinical practice. Methods: MEDLINE was searched until February 2018 for randomized trials …

Myocardial infarction without obstructive coronary artery disease is not a benign condition (ANZACS-QI 10)

PR Barr, W Harrison, D Smyth, C Flynn, M Lee… - Heart, Lung and …, 2018 - Elsevier
Background Non-obstructive coronary artery disease (CAD) on coronary angiography after
myocardial infarction (MI) is associated with a lower risk of adverse outcomes, but the …

Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study

R Pylypchuk, S Wells, A Kerr, K Poppe, M Harwood… - The Lancet, 2021 - thelancet.com
Background Until recently, most patients with diabetes worldwide have been diagnosed
when symptomatic and have high cardiovascular risk, meaning most should be prescribed …

[HTML][HTML] Prediction of cardiovascular disease risk among people with severe mental illness: a cohort study

R Cunningham, K Poppe, D Peterson, S Every-Palmer… - PloS one, 2019 - journals.plos.org
Objective To determine whether contemporary sex-specific cardiovascular disease (CVD)
risk prediction equations underestimate CVD risk in people with severe mental illness from …

Outcome after myocardial infarction without obstructive coronary artery disease

MJA Williams, PR Barr, M Lee, KK Poppe, AJ Kerr - Heart, 2019 - heart.bmj.com
Objective The medium-term outcome and cause of death in patients with myocardial
infarction with non-obstructive coronary arteries (MINOCA) is not well characterised. The aim …

[HTML][HTML] A mental models approach for defining explainable artificial intelligence

M Merry, P Riddle, J Warren - BMC Medical Informatics and Decision …, 2021 - Springer
Background Wide-ranging concerns exist regarding the use of black-box modelling methods
in sensitive contexts such as healthcare. Despite performance gains and hype, uptake of …

Annual risk of major bleeding among persons without cardiovascular disease not receiving antiplatelet therapy

V Selak, A Kerr, K Poppe, B Wu, M Harwood, C Grey… - Jama, 2018 - jamanetwork.com
Importance A decision to initiate aspirin therapy for primary prevention of cardiovascular
disease (CVD) requires consideration of both treatment benefits and harms. The most …